PHS
RZLT icon

PFM Health Sciences’s Rezolute RZLT Stock Holding History

PFM Health Sciences’s Portfolio RZLT Stock Details RZLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$662K Sell
127,289
-1,437
-1% -$5.34K 0.06% 97
2026
Q1 		$393K Sell
128,726
-77,539
-38% -$233K 0.04% 83
2025
Q4 		$487K Sell
206,265
-246,468
-54% -$1.93M 0.05% 76
2025
Q3 		$4.26M Buy
452,733
+18,599
+4% +$124K 0.33% 55
2025
Q2 		$1.94M Buy
+434,134
New +$1.61M 0.16% 49

Other funds holding RZLT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PFM Health Sciences's RZLT Position: Q2 2026 in Review

PFM Health Sciences reduced its Rezolute (RZLT) stake by 1.1% in Q2 2026, selling an estimated $5.34K and leaving 127,289 shares worth $662K. The position accounts for 0.06% of the portfolio, ranked #97.

PFM Health Sciences first reported a position in RZLT in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.26M in Q3 2025. 144 funds tracked by Wall St. Rank hold RZLT as of Q2 2026.

  • PFM Health Sciences held 127,289 shares of Rezolute worth $662K as of Q2 2026.
  • PFM Health Sciences sold 1,437 Rezolute shares in Q2 2026, an estimated $5.34K.
  • Rezolute made up 0.06% of PFM Health Sciences's portfolio in Q2 2026, its #97 holding.
  • PFM Health Sciences first reported a position in Rezolute in Q2 2025 and has held it in 5 quarters since.
  • PFM Health Sciences's Rezolute position peaked at $4.26M in Q3 2025.
  • 144 funds tracked by Wall St. Rank held Rezolute as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.